Compare Amphastar Pharmaceuticals Inc (AMPH) vs Google Inc (GOOG) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Alphabet (GOOG) trades at $355.03, down 0.34% on the day, with a neutral technical signal and strong fundamental performance. The stock shows robust revenue growth, with 2025 revenue reaching $402.84 billion and net income of $132.17 billion, supported by consistent earnings beats. Analyst consensus is overwhelmingly bullish with an 86.84% buy rating and a $457.50 price target, indicating significant upside potential from current levels.

The outlook for GOOG remains positive driven by AI investments and cloud growth, but risks include regulatory scrutiny and high valuation multiples. With strong cash flow generation and institutional support, the stock presents a compelling opportunity for growth-oriented investors, though market volatility and competitive pressures warrant monitoring.